Device/Drug Combinations to Prevent Lymphedema
Stanford will tackle chronic lymphedema, which affects nearly one in three breast cancer survivors. A tiny implant paired with a specialized drug is placed at the site of damage, working together to help the body regrow lost lymphatic vessels and restore normal drainage.